Steven J. Gallinger
Mount Sinai Hospital
Canada
Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 475 publications
Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals.
Journal: medRxiv : the preprint server for health sciences
Published: May 04, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.
Journal: JCO clinical cancer informatics
Published: April 29, 2026
Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 26, 2026
GATA6 immunohistochemistry and prognosis after surgical resection of pancreatic adenocarcinoma: results from the ESPAC-4 trial.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Immunohistochemical and Genetic Evidence of Lynch Syndrome-Related Well-Differentiated Pancreatic Neuroendocrine Tumor in Association with Peliosis of the Non-Tumorous Islets and Ductulo-Insular Complexes: An Expansion of Endocrine Manifestations of Lynch Syndrome.
Journal: Endocrine pathology
Published: January 18, 2026
Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models.
Journal: NPJ precision oncology
Published: January 06, 2026
Development of Machine Learning Systems to Predict Cancer-Related Symptoms With Validation Across a Health Care System.
Journal: JCO clinical cancer informatics
Published: September 25, 2025
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 24, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 10, 2025
AI-Based Segmentation Reduces the Retrospective Miss Rate of Pancreatic Ductal Adenocarcinoma.
Journal: Journal of imaging informatics in medicine
Published: August 23, 2025
Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data.
Journal: JAMA oncology
Published: August 21, 2025
Alcohol consumption and molecular subtypes of colorectal cancer: pooled observational and Mendelian randomization analyses.
Journal: The American journal of clinical nutrition
Published: August 04, 2025
Last Updated: 09/26/2026